HILO-HF Registry: High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure

NCT03110042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-04-26

No results posted yet for this study

Summary

The HILO-HF Registry is a single centre registry that will be performed to provide information on the usual baseline oxygen saturation (SpO2) in patients presenting to ED with a primary ED diagnosis of AHF

Conditions

  • Acute Heart Failure

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Justin Ezekowitz, MD · University of Alberta

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03110042 on ClinicalTrials.gov